How Should Free Testosterone Be Monitored On TRT?
Timeline
Timestamp
Topic
00:00
A physician assistant asks how free testosterone should be interpreted in men on TRT, and Dr. O’Connor explains why injectable testosterone creates changing peaks and troughs that make laboratory timing critical.
01:10
Dr. O’Connor explains steady-state pharmacology and why smaller divided testosterone doses can reduce the large fluctuations produced by longer intervals between injections.
02:45
The discussion focuses on nadir testing and practical microdosing, with Dr. O’Connor emphasizing the lowest effective testosterone dose rather than large injections every two weeks or monthly.
04:40
Dr. O’Connor explains why free testosterone can become disproportionately high when testosterone and other androgens lower SHBG, making total and free testosterone behave differently.
06:55
Dr. O’Connor discusses allowing free testosterone near or slightly above the laboratory upper range at nadir when a man feels well and his ABCDs™ and androgen-related side effects remain controlled.
08:21
The discussion returns to individualized TRT dosing, with Dr. O’Connor emphasizing practical injection schedules, psychiatric health, estrogen effects, blood pressure, and lowering testosterone when symptoms or health markers worsen.
Video Summary
A physician assistant asks how free testosterone should be interpreted in men receiving injectable TRT. Dr. O’Connor explains that testosterone levels are highly dynamic after an injection, so a laboratory result represents only one moment within a changing peak-and-trough cycle.
The discussion focuses on reaching steady state, testing near the nadir or trough, and using smaller divided testosterone doses to reduce large hormonal fluctuations. Dr. O’Connor explains that injection frequency must remain practical for the individual and that the lowest effective dose should be judged by symptoms, total and free testosterone, SHBG, and overall tolerability rather than by one laboratory number.
Free testosterone can appear disproportionately high because testosterone and other androgens can lower SHBG, leaving more hormone unbound. Dr. O’Connor ultimately emphasizes individualized treatment through the ABCDs™, including A1C, blood pressure, cholesterol, red blood cell measurements, ferritin, mental health, and androgen-related side effects before deciding whether a free testosterone level is acceptable.
Drug Callouts
Drug
Description
Testosterone
Testosterone is the central hormone discussed because injectable TRT produces changing peak and trough levels that affect total and free testosterone measurements. Dr. O’Connor emphasizes reaching steady state, testing near the nadir, and using the lowest effective dose that maintains symptoms and broader health markers.
Testosterone Cypionate
Testosterone cypionate is discussed as a commonly used long-acting TRT ester that can be divided into smaller injections. Dr. O’Connor uses its pharmacokinetics to explain why laboratory timing and injection frequency influence interpretation of testosterone levels.
Testosterone Enanthate
Testosterone enanthate is discussed alongside cypionate because the two esters have similar long-acting pharmacokinetics. Dr. O’Connor explains that either can be divided into smaller doses to reduce large hormonal peaks and troughs.
Sustanon 250
Sustanon 250 is mentioned as another injectable testosterone formulation whose levels change substantially after dosing. Dr. O’Connor includes it while explaining why men on TRT should interpret laboratory values according to the pharmacokinetics and timing of their specific testosterone preparation.
Testosterone Propionate
Testosterone propionate is mentioned while comparing different testosterone esters and their pharmacokinetic behavior. Dr. O’Connor emphasizes that the specific formulation and its half-life influence how frequently testosterone should be administered and when laboratory testing is meaningful.
Condition Callouts
Condition
Description
Androgen-Induced Erythrocytosis
Dr. O’Connor discusses accelerated red blood cell production as an important effect of testosterone and other androgens. Men on TRT should have hemoglobin and hematocrit interpreted alongside ferritin and broader iron studies rather than evaluating the CBC in isolation.
Hereditary Hemochromatosis
Dr. O’Connor highlights unusually high ferritin as a possible warning sign for hereditary hemochromatosis and iron deposition. In men using testosterone, elevated red blood cell measurements should not distract from identifying excessive iron accumulation when ferritin is high.
Hypertension
High blood pressure is one of the health problems Dr. O’Connor watches when deciding whether a testosterone dose is excessive. Men on TRT with very high free testosterone, bloating, or other androgenic effects may need the dose reduced when hypertension develops or worsens.
Anxiety And Depression
Dr. O’Connor emphasizes psychiatric health when adjusting testosterone because anxiety and depression may reflect the individual’s underlying condition, androgen exposure, or excessive manipulation of estrogen. Mental health therefore remains part of determining whether a TRT regimen is sustainable.
Gynecomastia
Gynecomastia is mentioned among the androgen- and estrogen-related effects that can influence how aggressively testosterone is dosed. Dr. O’Connor emphasizes adjusting treatment to the individual rather than pursuing high free testosterone without considering unwanted physical effects.
Key Takeaways
- A testosterone laboratory result is only a snapshot because injectable TRT produces changing levels throughout the dosing interval.
- Testing near the nadir or trough provides more useful information for judging whether an established TRT dose is excessive or appropriate.
- Smaller divided testosterone doses can reduce large peaks and troughs, but the injection schedule must remain practical enough for the individual to maintain.
- Free testosterone may appear disproportionately high when testosterone or other androgens lower SHBG and leave more hormone unbound.
- Dr. O’Connor may accept free testosterone near or slightly above the laboratory upper range at nadir when symptoms and ABCDs™ remain favorable.
- TRT dosing should be reduced when excessive androgen exposure is accompanied by problems such as anxiety, bloating, hypertension, or other adverse effects.